查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1606431

连续血糖监测市场，按组件类型、按方式、按产品类型、按患者类型、按配销通路、按国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Continuous Glucose Monitoring Market, By Component Type, By Modality, By Product Type, By Patient Type, By Distribution Channel, By Country, and By Region -Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年，连续血糖监测市场规模为 113.2932 亿美元，2024 年至 2032 年复合年增长率为 12.79%。

连续血糖监测市场-市场动态

非侵入性血糖监测技术提供了更舒适、方便的替代方案。

非侵入性血糖监测技术正在蓬勃发展，因为它们有可能为传统指尖采血测试提供更舒适、更方便的替代方案。连续血糖监测市场的主要驱动力包括生物感测器技术的进步，该技术无需皮肤穿透即可实现更准确、更可靠的测量。非侵入性方法，例如透过汗水、眼泪或红外线进行监测，可以减少不适和感染风险，这对需要频繁监测的患者很有吸引力。此外，糖尿病患者和医疗保健提供者对无痛、用户友好型设备的日益青睐也推动了其采用。

非侵入性技术还有望扩大血糖监测对更广泛用户的吸引力，包括那些有糖尿病风险的用户。这些系统的便利性可以提高患者的依从性并加强整体疾病管理。根据美国国立卫生研究院 (NIH) 的数据，估计有三分之一的美国成年人面临糖尿病的风险，这进一步推动了对更方便、侵入性更小的监测解决方案的需求。随着政府和学术界对非侵入性技术的支持不断增加，随着研究人员探索更多创新的糖尿病管理解决方案，市场有望成长。

连续血糖监测市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 12.79% 左右的复合年增长率成长

根据组件类型细分，感测器是 2023 年的领先细分市场

根据模态细分，侵入性是 2023 年的领先细分市场

根据产品类型细分，连续血糖监测系统 (CGMS) 预计将在 2023 年显示最大的市场份额

根据患者类型细分，1 型糖尿病是 2023 年的主要细分市场

根据配销通路细分，零售销售是 2023 年的领先细分市场

按地区划分，北美是 2023 年的主要收入来源

连续血糖监测市场-細項分析：

全球连续血糖监测市场根据组件类型、模式、产品类型、患者类型、配销通路和地区进行细分。

根据产品类型，市场分为两类：连续血糖监测系统（CGMS）和自我监测血糖系统（SMBG）。在连续血糖监测系统 (CGMS) 市场中，主导部分是穿戴式 CGMS，特别是基于感测器的装置。这些系统提供即时、连续的血糖资料，为糖尿病患者，尤其是第 1 型糖尿病患者带来显着益处。对更准确、用户友好和微创解决方案不断增长的需求推动了可穿戴式 CGMS 的采用，它可以与智慧型手机或胰岛素帮浦集成，以实现自动资料追踪和管理。该技术不仅提高了患者的便利性，还改善了血糖控制，使其成为市场成长的关键驱动力。

市场依模式分为两类：侵入式 CGM 和非侵入式 CGM。侵入性连续血糖监测 (CGM) 系统是市场上最主要的部分。这些系统涉及皮下感测器，可连续即时监测血糖水平，提供准确可靠的资料。它们提供关键功能，例如低血糖或高血糖警报，以及与胰岛素帮浦和智慧型手机的整合。侵入式 CGM 的主导地位归功于其经过验证的准确性、广泛的监管批准以及领先製造商的强大市场影响力。儘管非侵入性系统不断发展，但侵入性 CGM 仍然是有效管理糖尿病的首选。

连续血糖监测市场 - 地理洞察

由于糖尿病发病率上升以及人们对血糖管理重要性的认识不断提高，北美连续血糖监测 (CGM) 市场的格局正在迅速扩大。美国占据最大份额，1 型和 2 型糖尿病患者越来越多地采用 CGM 系统，因为它们能够提供即时资料、改善血糖控制并减少併发症。技术的进步，例如更小、更便宜和用户友好的设备，也推动了市场的成长。 CGM 装置与行动应用程式和其他数位健康解决方案的整合进一步增强了它们的吸引力。此外，糖尿病相关併发症的日益流行，加上预防性医疗保健的推动，对 CGM 系统产生了强劲的需求。 FDA 等机构的监管批准和有利的报销政策正在进一步加速采用。由于医疗保健系统优先考虑慢性病管理和个人化医疗，预计美国和加拿大的市场将持续成长。

连续血糖监测市场-竞争格局：

连续血糖监测 (CGM) 市场竞争格局的特点是既有成熟企业，也有专注于创新糖尿病管理解决方案的新兴公司。 Abbott、Dexcom 和 Medtronic 等领先公司凭藉其先进的 CGM 系统占据市场主导地位，这些系统提供即时血糖监测、与胰岛素帮浦整合以及行动应用程式连接。 Abbott 的 FreeStyle Libre 和 Dexcom 的 G6/G7 系统是使用最广泛的系统之一。美敦力也凭藉其 Guardian Connect 系统保持了强势地位。像 Senseonics 这样的新进业者及其植入式 Eversense CGM，为市场带来了独特的解决方案，提供更长的感测器寿命。该市场竞争激烈，各公司在感测器准确性、易用性、定价和患者资料管理能力等因素上竞争。 CGM 製造商与胰岛素提供者或行动健康应用程式等製药或科技公司之间的合作进一步加剧了竞争，推动了市场的创新和成长。此外，监管批准和报销政策对于塑造竞争动态至关重要。

最新进展：

2024 年 2 月，Dexcom, Inc. 推出了最新的连续血糖监测 (CGM) Dexcom ONE+，以加强为比利时、西班牙和波兰患者提供强大的新型糖尿病护理技术。

2024 年 1 月，雅培 (Abbott) 和胰岛素输送和糖尿病技术领域的 Tandem Diabetes Care, Inc. 推出了采用 Control-IQ 技术的 t: slim X2 胰岛素泵，使其成为美国首个将使用FreeStyle Libre 2 Plus感应器.这使该组织能够加强其产品组合。

2024 年1 月，美敦力(Medtronic) 的MiniMed 780G 系统获得了CE 批准，该系统配备Simplera Sync，这是一种一次性一体式连续血糖监测仪(CGM)，不需要指尖采血或胶带，以加强其产品线。带来

目录

第一章：连续血糖监测市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按组件类型分類的连续血糖监测市场片段
    • 按模式分類的连续血糖监测市场片段
    • 按产品类型分類的连续血糖监测市场片段
    • 按患者类型分類的连续血糖监测市场片段
    • 按配销通路分類的连续血糖监测市场片段
    • 按国家/地区分類的连续血糖监测市场片段
    • 按地区分類的连续血糖监测市场片段
  • 竞争洞察

第 3 章：连续血糖监测主要市场趋势

  • 连续血糖监测市场驱动因素
    • 市场驱动因素的影响分析
  • 连续血糖监测市场限制
    • 市场限制影响分析
  • 连续血糖监测市场机会
  • 连续血糖监测市场未来趋势

第 4 章：连续血糖监测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：连续血糖监测市场：地缘政治紧张局势升级的影响

  • COVID-19 大流行的影响
  • 俄罗斯-乌克兰战争的影响
  • 中东衝突的影响

第 6 章：连续血糖监测市场格局

  • 2023 年连续血糖监测市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：连续血糖监测市场 - 依组件类型

  • 概述
    • 按组件类型分類的细分市场份额分析
    • 发射器和接收器
    • 感应器

第 8 章：连续血糖监测市场 - 按模式

  • 概述
    • 按方式分類的细分市场占有率分析
    • 非侵入性
    • 侵入性

第 9 章：连续血糖监测市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
      • 自我监测血糖 (SMBG) 系统
      • 连续血糖监测 (CBGM) 系统

第 10 章：连续血糖监测市场 - 依病患类型

  • 概述
    • 按患者类型分類的细分市场份额分析
    • 1 型糖尿病
    • 2 型糖尿病

第 11 章：连续血糖监测市场 - 按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 机构销售
    • 零售销售
    • 其他的

第 12 章：连续血糖监测市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美连续血糖监测主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按组件类型）
    • 北美市场规模和预测（按方式）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按患者类型）
    • 北美市场规模和预测（按配销通路）
    • 美国
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲连续血糖监测主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按组件类型）
    • 欧洲市场规模与预测（按方式）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按患者类型）
    • 欧洲市场规模和预测（按配销通路）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区连续血糖监测主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按组件类型）
    • 亚太地区市场规模与预测（按方式）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模和预测（按患者类型）
    • 亚太地区市场规模和预测（按配销通路）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲连续血糖监测主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按组件类型）
    • 拉丁美洲市场规模与预测（按方式）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按患者类型）
    • 拉丁美洲市场规模和预测（按配销通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲连续血糖监测主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按组件类型）
    • 中东和非洲市场规模及预测（按方式）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按患者类型）
    • 中东和非洲市场规模及预测（按配销通路）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 13 章：主要供应商分析 - 连续血糖监测产业

  • 竞争仪表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Abbott Laboratories
    • Dexcom, Inc.
    • Medtronic plc
    • Senseonics Holdings, Inc.
    • Roche Diagnostics
    • LifeScan, Inc.
    • Ascensia Diabetes Care
    • Tandem Diabetes Care, Inc.
    • Insulet Corporation
    • Ypsomed Holding AG
    • Johnson & Johnson
    • GlucoWise
    • Beta Bionics
    • Pear Therapeutics
    • Diasend
    • F. Hoffmann-La Roche AG
    • Novo Nordisk A/S
    • Glooko, Inc.

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4256

REPORT HIGHLIGHT

Continuous Glucose Monitoring Market size was valued at USD 11,329.32 Million in 2023, expanding at a CAGR of 12.79% from 2024 to 2032.

The Continuous Glucose Monitoring (CGM) market refers to the sector that develops and supplies devices designed to track glucose levels in real-time throughout the day and night. These devices are primarily used by individuals with diabetes to manage their blood sugar levels more effectively, reducing the need for frequent fingerstick testing. CGMs work by using a sensor placed under the skin to measure glucose in the interstitial fluid, transmitting data to a receiver or smartphone. The market has seen significant growth due to rising diabetes prevalence, increasing awareness about diabetes management, and technological advancements that have made CGMs more accurate, affordable, and user-friendly. CGMs also offer features like alerts for hypo- or hyperglycemia and integration with insulin pumps, providing enhanced control. As healthcare systems emphasize preventative care, the demand for CGMs is expected to continue rising, creating opportunities for innovation and expansion in the market.

Continuous Glucose Monitoring Market- Market Dynamics

Non-invasive glucose monitoring technologies offer more comfortable, convenient alternatives.

Non-invasive glucose monitoring technologies are gaining momentum due to their potential to offer more comfortable, convenient alternatives to traditional fingerstick testing. Key drivers for the Continuous Glucose Monitoring Market include advancements in biosensor technology, which are enabling more accurate and reliable measurements without the need for skin penetration. Non-invasive methods, such as monitoring through sweat, tears, or infrared light, reduce discomfort and the risk of infection, which appeals to patients who require frequent monitoring. Furthermore, the growing preference for painless, user-friendly devices among diabetic patients and healthcare providers is fueling adoption.

Non-invasive technologies also promise to broaden the appeal of glucose monitoring to a wider range of users, including those at risk of developing diabetes. The convenience of these systems can improve patient compliance and enhance overall disease management. According to the National Institutes of Health (NIH), an estimated 1 in 3 American adults is at risk of developing diabetes, further driving the demand for more accessible and less invasive monitoring solutions. With increasing government and academic support for non-invasive technologies, the market is poised for growth as researchers explore more innovative solutions for diabetes management.

Continuous Glucose Monitoring Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.79% over the forecast period (2024-2032)

Based on Component Type segmentation, Sensors was the leading segment in 2023

Based on Modality segmentation, Invasive was the leading segment in 2023

Based on Product Type segmentation, Continuous Glucose Monitoring Systems (CGMS) was predicted to show maximum market share in the year 2023

Based on Patient Type segmentation, Type 1 diabetes was the leading segment in 2023

Based on Distribution Channel segmentation, Retail Sales was the leading segment in 2023

based on Region, North America was the leading revenue generator in 2023

Continuous Glucose Monitoring Market- Segmentation Analysis:

The Global Continuous Glucose Monitoring Market is segmented based on Component Type, Modality, Product Type, Patient Type, Distribution Channel, and Region.

The market is divided into two categories based on Product Type: Continuous Glucose Monitoring Systems (CGMS) and Self-Monitoring Blood Glucose Systems (SMBG). In the Continuous Glucose Monitoring Systems (CGMS) market, the dominant segment is the wearable CGMS, particularly the sensor-based devices. These systems provide real-time, continuous glucose data, offering significant benefits for patients with diabetes, especially those with Type 1 diabetes. The growing demand for more accurate, user-friendly, and minimally invasive solutions has driven the adoption of wearable CGMS, which can be integrated with smartphones or insulin pumps for automated data tracking and management. This technology not only enhances patient convenience but also improves glycemic control, making it a key driver in the market's growth.

The market is divided into two categories based on Modality: Invasive CGM and Non-Invasive CGM. Invasive Continuous Glucose Monitoring (CGM) systems are the most dominant segment in the market. These systems involve a subcutaneous sensor that continuously monitors glucose levels in real time, providing accurate and reliable data. They offer key features such as alerts for hypo- or hyperglycemia, and integration with insulin pumps and smartphones. The dominance of invasive CGMs is due to their proven accuracy, extensive regulatory approvals, and strong market presence from leading manufacturers. Despite the ongoing development of non-invasive systems, invasive CGMs remain the preferred choice for managing diabetes effectively.

Continuous Glucose Monitoring Market- Geographical Insights

The North American landscape for the Continuous Glucose Monitoring (CGM) market is rapidly expanding, driven by rising incidences of diabetes and increasing awareness about the importance of glucose management. The U.S. holds the largest share, with both Type 1 and Type 2 diabetes patients increasingly adopting CGM systems due to their ability to provide real-time data, improve glycemic control, and reduce complications. Advancements in technology, such as smaller, more affordable, and user-friendly devices, are also fueling market growth. The integration of CGM devices with mobile apps and other digital health solutions is further enhancing their appeal. Moreover, the growing prevalence of diabetes-related complications, coupled with the push for preventive healthcare, is creating a strong demand for CGM systems. Regulatory approvals from bodies like the FDA and favorable reimbursement policies are further accelerating adoption. As healthcare systems prioritize chronic disease management and personalized medicine, the market is expected to see continued growth in both the U.S. and Canada.

Continuous Glucose Monitoring Market- Competitive Landscape:

The competitive landscape of the Continuous Glucose Monitoring (CGM) market is characterized by a mix of established players and emerging companies focused on innovative diabetes management solutions. Leading companies like Abbott, Dexcom, and Medtronic dominate the market, with their advanced CGM systems offering real-time glucose monitoring, integration with insulin pumps, and mobile app connectivity. Abbott's FreeStyle Libre and Dexcom's G6/G7 systems are among the most widely used. Medtronic also maintains a strong position with its Guardian Connect system. Newer entrants like Senseonics, with its implantable Eversense CGM, bring unique solutions to the market, offering longer sensor life. The market is highly competitive with companies competing on factors like sensor accuracy, ease of use, pricing, and patient data management capabilities. Partnerships between CGM manufacturers and pharmaceutical or tech companies, such as insulin providers or mobile health apps, further intensify competition, driving innovation and growth in the market. Furthermore, regulatory approval and reimbursement policies are crucial in shaping the competitive dynamics.

Recent Developments:

In February 2024, Dexcom, Inc. introduces Dexcom ONE+, the latest Continuous Glucose Monitoring (CGM), to strengthen strong, new diabetes care technologies for patients in Belgium, Spain, and Poland.

In January 2024, Abbott and Tandem Diabetes Care, Inc., a player in insulin delivery and diabetes technologies, unveiled the t: slim X2 insulin pump with Control-IQ technology, making it the first automated insulin administration system in the United States to combine with the FreeStyle Libre 2 Plus sensor. This enabled the organization to strengthen its product portfolio.

In January 2024, Medtronic got CE approval for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one Continuous Glucose Monitor (CGM) that does not require fingersticks or overtape, to strengthen its product line. to bring

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Dexcom, Inc.
  • Medtronic plc
  • Senseonics Holdings, Inc.
  • Roche Diagnostics
  • LifeScan, Inc.
  • Ascensia Diabetes Care
  • Tandem Diabetes Care, Inc.
  • Insulet Corporation
  • Ypsomed Holding AG
  • Johnson & Johnson
  • GlucoWise
  • Beta Bionics
  • Pear Therapeutics
  • Diasend
  • F. Hoffmann-La Roche AG
  • Novo Nordisk A/S
  • Glooko, Inc.

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY COMPONENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Transmitters and Receivers
  • Sensors

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Non-invasive
  • Invasive

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Self-Monitoring Blood Glucose (SMBG) Systems
  • Continuous Blood Glucose Monitoring (CBGM) Systems

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Type-1 Diabetes
  • Type-2 Diabetes

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Institutional Sales
  • Retail Sales
  • Others

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Continuous Glucose Monitoring Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Continuous Glucose Monitoring Market Snippet by Component Type
    • 2.1.2. Continuous Glucose Monitoring Market Snippet by Modality
    • 2.1.3. Continuous Glucose Monitoring Market Snippet by Product Type
    • 2.1.4. Continuous Glucose Monitoring Market Snippet by Patient Type
    • 2.1.5. Continuous Glucose Monitoring Market Snippet by Distribution Channel
    • 2.1.6. Continuous Glucose Monitoring Market Snippet by Country
    • 2.1.7. Continuous Glucose Monitoring Market Snippet by Region
  • 2.2. Competitive Insights

3. Continuous Glucose Monitoring Key Market Trends

  • 3.1. Continuous Glucose Monitoring Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Continuous Glucose Monitoring Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Continuous Glucose Monitoring Market Opportunities
  • 3.4. Continuous Glucose Monitoring Market Future Trends

4. Continuous Glucose Monitoring Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Continuous Glucose Monitoring Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Continuous Glucose Monitoring Market Landscape

  • 6.1. Continuous Glucose Monitoring Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Continuous Glucose Monitoring Market - By Component Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component Type, 2023 & 2032 (%)
    • 7.1.2. Transmitters and Receivers
    • 7.1.3. Sensors

8. Continuous Glucose Monitoring Market - By Modality

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Modality, 2023 & 2032 (%)
    • 8.1.2. Non-invasive
    • 8.1.3. Invasive

9. Continuous Glucose Monitoring Market - By Product Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
      • 9.1.1.1. Self-Monitoring Blood Glucose (SMBG) Systems
      • 9.1.1.2. Continuous Blood Glucose Monitoring (CBGM) Systems

10. Continuous Glucose Monitoring Market - By Patient Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Patient Type, 2023 & 2032 (%)
    • 10.1.2. Type-1 Diabetes
    • 10.1.3. Type-2 Diabetes

11. Continuous Glucose Monitoring Market - By Distribution Channel

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 11.1.2. Institutional Sales
    • 11.1.3. Retail Sales
    • 11.1.4. Others

12. Continuous Glucose Monitoring Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Continuous Glucose Monitoring Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.2.9. The U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Continuous Glucose Monitoring Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Continuous Glucose Monitoring Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Continuous Glucose Monitoring Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Continuous Glucose Monitoring Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Continuous Glucose Monitoring Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. Dexcom, Inc.
    • 13.2.3. Medtronic plc
    • 13.2.4. Senseonics Holdings, Inc.
    • 13.2.5. Roche Diagnostics
    • 13.2.6. LifeScan, Inc.
    • 13.2.7. Ascensia Diabetes Care
    • 13.2.8. Tandem Diabetes Care, Inc.
    • 13.2.9. Insulet Corporation
    • 13.2.10. Ypsomed Holding AG
    • 13.2.11. Johnson & Johnson
    • 13.2.12. GlucoWise
    • 13.2.13. Beta Bionics
    • 13.2.14. Pear Therapeutics
    • 13.2.15. Diasend
    • 13.2.16. F. Hoffmann-La Roche AG
    • 13.2.17. Novo Nordisk A/S
    • 13.2.18. Glooko, Inc.

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us